董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Andrew Toy | 男 | Co-Founder, Chief Executive Officer and Director | 46 | 未披露 | 未持股 | 2025-10-31 |
| Vivek Garipalli | 男 | Co-Founder and Executive Chairperson | 46 | 未披露 | 未持股 | 2025-10-31 |
| Carladenise Armbrister Edwards | 女 | Director | 55 | 未披露 | 未持股 | 2025-10-31 |
| Demetrios L. Kouzoukas | 男 | Lead Independent Director | 49 | 未披露 | 未持股 | 2025-10-31 |
| Anna U. Loengard | 女 | Director | 56 | 未披露 | 未持股 | 2025-10-31 |
| William G. Robinson | 男 | Director | 60 | 未披露 | 未持股 | 2025-10-31 |
| Lee A. Shapiro | 男 | Director | 69 | 未披露 | 未持股 | 2025-10-31 |
| Thomas L. Tran | 男 | Director | 68 | 未披露 | 未持股 | 2025-10-31 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Andrew Toy | 男 | Co-Founder, Chief Executive Officer and Director | 46 | 未披露 | 未持股 | 2025-10-31 |
| Peter Kuipers | 男 | Chief Financial Officer | 53 | 未披露 | 未持股 | 2025-10-31 |
| Karen Soares | 女 | General Counsel and Corporate Secretary | 47 | 未披露 | 未持股 | 2025-10-31 |
| Brady Priest | 男 | Chief Executive Officer of Home Care | 49 | 未披露 | 未持股 | 2025-10-31 |
| Jamie L. Reynoso | 女 | Chief Executive Officer of Medicare Advantage | 56 | 未披露 | 未持股 | 2025-10-31 |
| Conrad Wai | 男 | Chief Executive Officer of Counterpart Health | 44 | 未披露 | 未持股 | 2025-10-31 |
董事简历
中英对照 | 中文 | 英文- Andrew Toy
-
Andrew Toy，自2023年1月1日起担任首席执行官，自2018年11月起担任董事会成员。在成为首席执行官之前，他自2019年3月起担任总裁。此前，他还曾在2018年2月至2022年2月期间担任首席技术官。在加入Clover Health之前，从2014年5月到2018年2月，Toy先生就职于跨国科技公司Google LLC。他曾在谷歌云团队工作，负责开发人员平台和智能功能，并领导了安卓的企业平台Android for Work。Toy先生是在2014年5月收购Divide后加入谷歌的，Divide是一家专注于在移动设备上创造工作和个人数据分割的公司。从2010年1月通过收购开始，Toy先生担任Divide的首席执行官、董事和联合创始人。Toy先生拥有斯坦福大学计算机科学学士和硕士学位，他还曾在2000年6月至2001年4月期间担任副讲师。
Andrew Toy,has served as Chief Executive Officer since January 1, 2023, and as a member of Board of Directors since November 2018. Prior to becoming Chief Executive Officer, he had served as President since March 2019. He previously also served as Chief Technology Officer from February 2018 to February 2022. Prior to joining Clover Health, from May 2014 to February 2018, Mr. Toy was at Google LLC, a multinational technology company. He worked on the Google Cloud team where he was responsible for Developer Platform and Intelligence features, and led Android for Work, the enterprise platform for Android. Mr. Toy joined Google as a result of the May 2014 acquisition of Divide, a company focused on creating a split between work and personal data on mobile devices From January 2010 through its acquisition, Mr. Toy was the Chief Executive Officer, a director and co-founder of Divide. Mr. Toy holds a B.S. and an M.S. in computer science from Stanford University, where he has also served as an associate lecturer from June 2000 to April 2001. - Andrew Toy，自2023年1月1日起担任首席执行官，自2018年11月起担任董事会成员。在成为首席执行官之前，他自2019年3月起担任总裁。此前，他还曾在2018年2月至2022年2月期间担任首席技术官。在加入Clover Health之前，从2014年5月到2018年2月，Toy先生就职于跨国科技公司Google LLC。他曾在谷歌云团队工作，负责开发人员平台和智能功能，并领导了安卓的企业平台Android for Work。Toy先生是在2014年5月收购Divide后加入谷歌的，Divide是一家专注于在移动设备上创造工作和个人数据分割的公司。从2010年1月通过收购开始，Toy先生担任Divide的首席执行官、董事和联合创始人。Toy先生拥有斯坦福大学计算机科学学士和硕士学位，他还曾在2000年6月至2001年4月期间担任副讲师。
- Andrew Toy,has served as Chief Executive Officer since January 1, 2023, and as a member of Board of Directors since November 2018. Prior to becoming Chief Executive Officer, he had served as President since March 2019. He previously also served as Chief Technology Officer from February 2018 to February 2022. Prior to joining Clover Health, from May 2014 to February 2018, Mr. Toy was at Google LLC, a multinational technology company. He worked on the Google Cloud team where he was responsible for Developer Platform and Intelligence features, and led Android for Work, the enterprise platform for Android. Mr. Toy joined Google as a result of the May 2014 acquisition of Divide, a company focused on creating a split between work and personal data on mobile devices From January 2010 through its acquisition, Mr. Toy was the Chief Executive Officer, a director and co-founder of Divide. Mr. Toy holds a B.S. and an M.S. in computer science from Stanford University, where he has also served as an associate lecturer from June 2000 to April 2001.
- Vivek Garipalli
-
Vivek Garipalli，2014年与他人共同创立Clover Health,2014年7月至2022年12月担任首席执行官。他自2014年7月起担任董事会成员，并被任命为董事会执行主席，自2023年1月1日起生效。Garipalli先生还在2014年7月至2019年3月期间担任总统。在加入Clover Health之前，Garipalli先生与他人共同创立了CarePoint Health和Ensemble Health Health。他于2008年至2022年担任CarePoint的联合创始人和董事会成员，这是一个医疗保健系统，为历史上服务不足的大量人群提供急症护理和急救服务。他于2014年至2016年在全国性医疗保健收入周期服务公司Ensemble Health担任联合创始人和董事会成员。在Flatiron Health，Garipalli先生作为早期投资者进入，并就其战略和商业模式提供建议，包括领导收购其数据平台Altos。随后，他通过2018年将Flatiron Health出售给罗氏，从2012年开始担任Flatiron Health的董事会成员。他还曾任职于或目前任职于Cityblock Health、Doctor Evidence、Medically Home、Thyme Care和Swiftly Systems Inc.的董事会。Garipalli先生的职业生涯始于金融领域，曾在瑞士信贷第一波士顿、J.P. Morgan Partners和黑石集团任职。Garipalli先生家族办公室的投资部门Wormhole Capital与有能力建立变革性、定义类别的公司的特殊创始人合作。Garipalli先生拥有埃默里大学创业学士学位。
Vivek Garipalli,co-founded Clover Health in 2014 and served as Chief Executive Officer from July 2014 to December 2022. He has been a member of Board of Directors since July 2014 and was appointed Executive Chairperson of the Board effective as of January 1, 2023. Mr. Garipalli also served as President from July 2014 to March 2019. Prior to Clover Health, Mr. Garipalli co-founded both CarePoint Health and Ensemble Health. He served as Co-Founder and Board Member from 2008 to 2022 at CarePoint, a healthcare system that offers acute care and emergency services to a large, historically underserved population. He served as Co-Founder and Board Member from 2014 to 2016 at Ensemble Health, a national healthcare revenue cycle services company. At Flatiron Health, Mr. Garipalli entered as an early investor and advised on its strategy and business model, including leading the acquisition of its data platform, Altos. He subsequently served on Flatiron Health's board from 2012 through its sale to Roche in 2018. He has also previously served or is currently serving on the boards of Cityblock Health, Doctor Evidence, Medically Home, Thyme Care and Swiftly Systems Inc. Mr. Garipalli began his career in finance, holding roles at Credit Suisse First Boston, J.P. Morgan Partners and Blackstone Group. Wormhole Capital, the investment arm of Mr. Garipalli's family office, partners with special founders with the aptitude to build transformative, category-defining companies. Mr. Garipalli holds a B.B.A. in entrepreneurship from Emory University. - Vivek Garipalli，2014年与他人共同创立Clover Health,2014年7月至2022年12月担任首席执行官。他自2014年7月起担任董事会成员，并被任命为董事会执行主席，自2023年1月1日起生效。Garipalli先生还在2014年7月至2019年3月期间担任总统。在加入Clover Health之前，Garipalli先生与他人共同创立了CarePoint Health和Ensemble Health Health。他于2008年至2022年担任CarePoint的联合创始人和董事会成员，这是一个医疗保健系统，为历史上服务不足的大量人群提供急症护理和急救服务。他于2014年至2016年在全国性医疗保健收入周期服务公司Ensemble Health担任联合创始人和董事会成员。在Flatiron Health，Garipalli先生作为早期投资者进入，并就其战略和商业模式提供建议，包括领导收购其数据平台Altos。随后，他通过2018年将Flatiron Health出售给罗氏，从2012年开始担任Flatiron Health的董事会成员。他还曾任职于或目前任职于Cityblock Health、Doctor Evidence、Medically Home、Thyme Care和Swiftly Systems Inc.的董事会。Garipalli先生的职业生涯始于金融领域，曾在瑞士信贷第一波士顿、J.P. Morgan Partners和黑石集团任职。Garipalli先生家族办公室的投资部门Wormhole Capital与有能力建立变革性、定义类别的公司的特殊创始人合作。Garipalli先生拥有埃默里大学创业学士学位。
- Vivek Garipalli,co-founded Clover Health in 2014 and served as Chief Executive Officer from July 2014 to December 2022. He has been a member of Board of Directors since July 2014 and was appointed Executive Chairperson of the Board effective as of January 1, 2023. Mr. Garipalli also served as President from July 2014 to March 2019. Prior to Clover Health, Mr. Garipalli co-founded both CarePoint Health and Ensemble Health. He served as Co-Founder and Board Member from 2008 to 2022 at CarePoint, a healthcare system that offers acute care and emergency services to a large, historically underserved population. He served as Co-Founder and Board Member from 2014 to 2016 at Ensemble Health, a national healthcare revenue cycle services company. At Flatiron Health, Mr. Garipalli entered as an early investor and advised on its strategy and business model, including leading the acquisition of its data platform, Altos. He subsequently served on Flatiron Health's board from 2012 through its sale to Roche in 2018. He has also previously served or is currently serving on the boards of Cityblock Health, Doctor Evidence, Medically Home, Thyme Care and Swiftly Systems Inc. Mr. Garipalli began his career in finance, holding roles at Credit Suisse First Boston, J.P. Morgan Partners and Blackstone Group. Wormhole Capital, the investment arm of Mr. Garipalli's family office, partners with special founders with the aptitude to build transformative, category-defining companies. Mr. Garipalli holds a B.B.A. in entrepreneurship from Emory University.
- Carladenise Armbrister Edwards
-
卡拉德尼斯·阿姆布里斯特·爱德华兹，自2022年7月起担任董事会成员。自2023年8月起，爱德华兹博士担任迈阿密戴德县首席行政官。从2020年7月到2022年8月，Edwards博士担任Henry Ford Health System的执行副总裁兼首席战略官，在那里她领导了该系统的战略规划工作和合作伙伴企业、业务发展和转型计划、政府事务战略，以及Henry Ford Innovations。在亨利·福特之前，爱德华兹博士于2018年7月至2020年6月担任卫生系统Providence St. Joseph Health的执行副总裁兼首席战略官，并于2017年1月至2018年7月担任Providence St. Joseph Health的高级副总裁。Edwards博士的经验包括担任多个额外的行政领导职务，包括Providence Health & Services的Population Health部门的首席行政官和Alameda Health System的首席战略官。爱德华兹博士还曾担任Cal eConnect，Inc.的创始总裁兼首席执行官，这是一家管理加州电子健康信息交易所的非营利性公司。此外，她还担任过佐治亚州社区卫生部的参谋长和临时专员。Edwards博士拥有佛罗里达大学医学社会学博士学位、宾夕法尼亚大学教育和心理服务硕士学位和社会学学士学位。
Carladenise Armbrister Edwards,has served as a member of Board of Directors since July 2022. Since August 2023, Dr. Edwards has served as Miami-Dade County's Chief Administrative Officer. From July 2020 to August 2022, Dr. Edwards served as the Executive Vice President and Chief Strategy Officer of the Henry Ford Health System, where she led the system's strategic planning efforts and partnership ventures, business development and transformation initiatives, government affairs strategy, as well as Henry Ford Innovations. Prior to Henry Ford, Dr. Edwards was Executive Vice President and Chief Strategy Officer for Providence St. Joseph Health, a health system, from July 2018 to June 2020, and the Senior Vice President, Contracting for Providence St. Joseph Health from January 2017 to July 2018. Dr. Edwards' experience includes several additional executive leadership roles, including Chief Administrative Officer for Providence Health & Services' Population Health division and Chief Strategy Officer for Alameda Health System. Dr. Edwards also served as Founding President and Chief Executive Officer of Cal eConnect, Inc., a nonprofit corporation that governed California's electronic Health Information Exchange. Additionally, she served as Chief of Staff and Interim Commissioner for Georgia's Department of Community Health. Dr. Edwards holds a Ph.D. in Medical Sociology from the University of Florida, a master's degree in education and psychological services and a bachelor's degree in sociology from the University of Pennsylvania. - 卡拉德尼斯·阿姆布里斯特·爱德华兹，自2022年7月起担任董事会成员。自2023年8月起，爱德华兹博士担任迈阿密戴德县首席行政官。从2020年7月到2022年8月，Edwards博士担任Henry Ford Health System的执行副总裁兼首席战略官，在那里她领导了该系统的战略规划工作和合作伙伴企业、业务发展和转型计划、政府事务战略，以及Henry Ford Innovations。在亨利·福特之前，爱德华兹博士于2018年7月至2020年6月担任卫生系统Providence St. Joseph Health的执行副总裁兼首席战略官，并于2017年1月至2018年7月担任Providence St. Joseph Health的高级副总裁。Edwards博士的经验包括担任多个额外的行政领导职务，包括Providence Health & Services的Population Health部门的首席行政官和Alameda Health System的首席战略官。爱德华兹博士还曾担任Cal eConnect，Inc.的创始总裁兼首席执行官，这是一家管理加州电子健康信息交易所的非营利性公司。此外，她还担任过佐治亚州社区卫生部的参谋长和临时专员。Edwards博士拥有佛罗里达大学医学社会学博士学位、宾夕法尼亚大学教育和心理服务硕士学位和社会学学士学位。
- Carladenise Armbrister Edwards,has served as a member of Board of Directors since July 2022. Since August 2023, Dr. Edwards has served as Miami-Dade County's Chief Administrative Officer. From July 2020 to August 2022, Dr. Edwards served as the Executive Vice President and Chief Strategy Officer of the Henry Ford Health System, where she led the system's strategic planning efforts and partnership ventures, business development and transformation initiatives, government affairs strategy, as well as Henry Ford Innovations. Prior to Henry Ford, Dr. Edwards was Executive Vice President and Chief Strategy Officer for Providence St. Joseph Health, a health system, from July 2018 to June 2020, and the Senior Vice President, Contracting for Providence St. Joseph Health from January 2017 to July 2018. Dr. Edwards' experience includes several additional executive leadership roles, including Chief Administrative Officer for Providence Health & Services' Population Health division and Chief Strategy Officer for Alameda Health System. Dr. Edwards also served as Founding President and Chief Executive Officer of Cal eConnect, Inc., a nonprofit corporation that governed California's electronic Health Information Exchange. Additionally, she served as Chief of Staff and Interim Commissioner for Georgia's Department of Community Health. Dr. Edwards holds a Ph.D. in Medical Sociology from the University of Florida, a master's degree in education and psychological services and a bachelor's degree in sociology from the University of Pennsylvania.
- Demetrios L. Kouzoukas
-
Demetrios L. Kouzoukas，自2021年4月起担任董事会成员。自2022年4月起，担任Team8 Partners的合伙人兼负责人，Team8 Partners是一家专注于网络安全、数据、金融科技和医疗保健的风险投资公司。在加入董事会之前，从2017年2月到2021年1月，Kouzoukas先生担任医疗保险中心主任以及医疗保险和医疗补助服务中心的首席副署长。此前，2012年至2016年，Kouzoukas先生担任健康保险公司UnitedHealthcare的医疗保险和退休业务总法律顾问。从2003年到2009年，Kouzoukas先生担任美国卫生与公众服务部（“HHS”）首席协理副部长，负责HHS各部门的监管政策，并担任副总法律顾问。2014年，Kouzoukas先生被任命为美国行政会议的公共成员。Kouzoukas先生拥有乔治华盛顿大学政治学和公共政策学士学位和伊利诺伊大学法学院法学博士学位。
Demetrios L. Kouzoukas,has served as a member of Board of Directors since April 2021. Since April 2022, he has served as a Partner and Principal of Team8 Partners, a venture capital firm focused on cybersecurity, data, fintech and healthcare. Prior to joining Board, from February 2017 until January 2021, Mr. Kouzoukas served as the Director of the Center for Medicare and the Principal Deputy Administrator of the Centers for Medicare and Medicaid Services. Previously, from 2012 to 2016, Mr. Kouzoukas served as General Counsel of the Medicare and Retirement business of UnitedHealthcare, a health insurance company. From 2003 to 2009, Mr. Kouzoukas was Principal Associate Deputy Secretary of the U.S. Department of Health and Human Services ("HHS"), with responsibility for regulatory policy across HHS, and Deputy General Counsel. In 2014, Mr. Kouzoukas was appointed a Public Member of the Administrative Conference of the United States. Mr. Kouzoukas holds a B.A. in political science and public policy from the George Washington University and a J.D. from the University of Illinois College of Law. - Demetrios L. Kouzoukas，自2021年4月起担任董事会成员。自2022年4月起，担任Team8 Partners的合伙人兼负责人，Team8 Partners是一家专注于网络安全、数据、金融科技和医疗保健的风险投资公司。在加入董事会之前，从2017年2月到2021年1月，Kouzoukas先生担任医疗保险中心主任以及医疗保险和医疗补助服务中心的首席副署长。此前，2012年至2016年，Kouzoukas先生担任健康保险公司UnitedHealthcare的医疗保险和退休业务总法律顾问。从2003年到2009年，Kouzoukas先生担任美国卫生与公众服务部（“HHS”）首席协理副部长，负责HHS各部门的监管政策，并担任副总法律顾问。2014年，Kouzoukas先生被任命为美国行政会议的公共成员。Kouzoukas先生拥有乔治华盛顿大学政治学和公共政策学士学位和伊利诺伊大学法学院法学博士学位。
- Demetrios L. Kouzoukas,has served as a member of Board of Directors since April 2021. Since April 2022, he has served as a Partner and Principal of Team8 Partners, a venture capital firm focused on cybersecurity, data, fintech and healthcare. Prior to joining Board, from February 2017 until January 2021, Mr. Kouzoukas served as the Director of the Center for Medicare and the Principal Deputy Administrator of the Centers for Medicare and Medicaid Services. Previously, from 2012 to 2016, Mr. Kouzoukas served as General Counsel of the Medicare and Retirement business of UnitedHealthcare, a health insurance company. From 2003 to 2009, Mr. Kouzoukas was Principal Associate Deputy Secretary of the U.S. Department of Health and Human Services ("HHS"), with responsibility for regulatory policy across HHS, and Deputy General Counsel. In 2014, Mr. Kouzoukas was appointed a Public Member of the Administrative Conference of the United States. Mr. Kouzoukas holds a B.A. in political science and public policy from the George Washington University and a J.D. from the University of Illinois College of Law.
- Anna U. Loengard
-
Anna U. Loengard，自2022年11月起担任董事会成员。自2022年12月起，Loengard博士担任Successful Caring LLC总裁，该公司为Oxeon Venture Studios、Rubicon Founders和Curana Health等客户提供战略性临床咨询。2020年8月至2022年10月，Loengard博士担任AccentCare的首席医疗官，该公司是一家提供家庭健康、临终关怀和私人护理服务的企业。此前，Loengard博士于2017年7月至2020年6月担任Caravan Health的首席医疗官；于2014年10月至2017年6月担任女王医疗保健系统临床综合医师网络的首席医疗官，并于2011年2月至2014年2月担任圣弗朗西斯医疗保健系统的首席医疗官，专注于急性后护理。她在纽约州立大学石溪分校获得医学博士学位，并在哈佛医学院、贝丝以色列女执事医疗中心完成了内科住院医师实习，并在亚利桑那大学完成了老年医学研究金。
Anna U. Loengard,has served on Board of Directors since November 2022. Since December 2022, Dr. Loengard has served as President of Successful Caring LLC, which provides strategic clinical consulting to clients such as Oxeon Venture Studios, Rubicon Founders and Curana Health. From August 2020 to October 2022, Dr. Loengard served as the Chief Medical Officer of AccentCare, an enterprise providing home health, hospice and private care services. Previously, Dr. Loengard served as the Chief Medical Officer for Caravan Health from July 2017 to June 2020; the Chief Medical Officer for the Queen's Healthcare System's Clinically Integrated Physician Network from October 2014 to June 2017, and the Chief Medical Officer at St. Francis Healthcare System from February 2011 to February 2014, focusing on post-acute care. She received her M.D. from the State University of New York at Stony Brook and completed her residency in Internal Medicine at Harvard Medical School, Beth Israel Deaconess Medical Center, and her Geriatrics Fellowship at the University of Arizona. - Anna U. Loengard，自2022年11月起担任董事会成员。自2022年12月起，Loengard博士担任Successful Caring LLC总裁，该公司为Oxeon Venture Studios、Rubicon Founders和Curana Health等客户提供战略性临床咨询。2020年8月至2022年10月，Loengard博士担任AccentCare的首席医疗官，该公司是一家提供家庭健康、临终关怀和私人护理服务的企业。此前，Loengard博士于2017年7月至2020年6月担任Caravan Health的首席医疗官；于2014年10月至2017年6月担任女王医疗保健系统临床综合医师网络的首席医疗官，并于2011年2月至2014年2月担任圣弗朗西斯医疗保健系统的首席医疗官，专注于急性后护理。她在纽约州立大学石溪分校获得医学博士学位，并在哈佛医学院、贝丝以色列女执事医疗中心完成了内科住院医师实习，并在亚利桑那大学完成了老年医学研究金。
- Anna U. Loengard,has served on Board of Directors since November 2022. Since December 2022, Dr. Loengard has served as President of Successful Caring LLC, which provides strategic clinical consulting to clients such as Oxeon Venture Studios, Rubicon Founders and Curana Health. From August 2020 to October 2022, Dr. Loengard served as the Chief Medical Officer of AccentCare, an enterprise providing home health, hospice and private care services. Previously, Dr. Loengard served as the Chief Medical Officer for Caravan Health from July 2017 to June 2020; the Chief Medical Officer for the Queen's Healthcare System's Clinically Integrated Physician Network from October 2014 to June 2017, and the Chief Medical Officer at St. Francis Healthcare System from February 2011 to February 2014, focusing on post-acute care. She received her M.D. from the State University of New York at Stony Brook and completed her residency in Internal Medicine at Harvard Medical School, Beth Israel Deaconess Medical Center, and her Geriatrics Fellowship at the University of Arizona.
- William G. Robinson
-
William G. Robinson，自2021年3月起担任董事会成员。Robinson先生自2018年10月起担任管理咨询公司Broadgate Human Capital，LLC的总裁。在加入Broadgate之前，Robinson先生于2013年12月至2017年9月期间担任旅行技术公司Sabre Corporation的执行副总裁兼首席人力资源官。在加入Sabre之前，Robinson先生于2012年至2013年在多元化管理式医疗保健公司考文垂保健担任高级副总裁兼首席人力资源官。2010年至2011年，Robinson先生在Outcomes Health Information Solutions担任人力资源高级副总裁，该公司是一家医疗保健分析和信息公司，专门从事医疗记录的优化和获取。在此之前，从1990年到2010年，他曾任职于通用电气，在多个行业担任过多个人力资源领导职务，包括信息技术、医疗保健、能源、安全和工业。Robinson先生自2016年6月起担任美国公共教育公司董事会成员，自2020年5月起担任美国公立大学系统董事会成员。Robinson先生拥有Wake Forest大学的传播学学士学位和Bowie州立大学的人力资源硕士学位。
William G. Robinson,has served as a member of Board of Directors since March 2021. Mr. Robinson has served as the President of Broadgate Human Capital, LLC, a management consulting firm, since October 2018. Prior to Broadgate, Mr. Robinson served as the Executive Vice President and Chief Human Resources Officer for Sabre Corporation, a travel technology company, from December 2013 to September 2017. Prior to Sabre, Mr. Robinson served as the Senior Vice President and Chief Human Resources Officer at Coventry Health Care, a diversified managed health care company, from 2012 to 2013. From 2010 to 2011, Mr. Robinson served as Senior Vice President of human resources at Outcomes Health Information Solutions, a healthcare analytics and information company specializing in the optimization and acquisition of medical records. Prior to that, from 1990 to 2010, he worked for General Electric, where he held several human resources leadership roles in diverse industries, including information technology, healthcare, energy, security and industrial. Mr. Robinson has served as a member of the board of directors of American Public Education, Inc. since June 2016 and as a member of the board of trustees for the American Public University System since May 2020. Mr. Robinson holds a B.A. in communications from Wake Forest University and an M.A. in human resources from Bowie State University. - William G. Robinson，自2021年3月起担任董事会成员。Robinson先生自2018年10月起担任管理咨询公司Broadgate Human Capital，LLC的总裁。在加入Broadgate之前，Robinson先生于2013年12月至2017年9月期间担任旅行技术公司Sabre Corporation的执行副总裁兼首席人力资源官。在加入Sabre之前，Robinson先生于2012年至2013年在多元化管理式医疗保健公司考文垂保健担任高级副总裁兼首席人力资源官。2010年至2011年，Robinson先生在Outcomes Health Information Solutions担任人力资源高级副总裁，该公司是一家医疗保健分析和信息公司，专门从事医疗记录的优化和获取。在此之前，从1990年到2010年，他曾任职于通用电气，在多个行业担任过多个人力资源领导职务，包括信息技术、医疗保健、能源、安全和工业。Robinson先生自2016年6月起担任美国公共教育公司董事会成员，自2020年5月起担任美国公立大学系统董事会成员。Robinson先生拥有Wake Forest大学的传播学学士学位和Bowie州立大学的人力资源硕士学位。
- William G. Robinson,has served as a member of Board of Directors since March 2021. Mr. Robinson has served as the President of Broadgate Human Capital, LLC, a management consulting firm, since October 2018. Prior to Broadgate, Mr. Robinson served as the Executive Vice President and Chief Human Resources Officer for Sabre Corporation, a travel technology company, from December 2013 to September 2017. Prior to Sabre, Mr. Robinson served as the Senior Vice President and Chief Human Resources Officer at Coventry Health Care, a diversified managed health care company, from 2012 to 2013. From 2010 to 2011, Mr. Robinson served as Senior Vice President of human resources at Outcomes Health Information Solutions, a healthcare analytics and information company specializing in the optimization and acquisition of medical records. Prior to that, from 1990 to 2010, he worked for General Electric, where he held several human resources leadership roles in diverse industries, including information technology, healthcare, energy, security and industrial. Mr. Robinson has served as a member of the board of directors of American Public Education, Inc. since June 2016 and as a member of the board of trustees for the American Public University System since May 2020. Mr. Robinson holds a B.A. in communications from Wake Forest University and an M.A. in human resources from Bowie State University.
- Lee A. Shapiro
-
Lee A. Shapiro，2002年成为Allscripts的总裁；2000年加入Allscripts。他指导着本公司的战略举措，其中包括最近完成的与Eclipsys and Misys的交易、之前与 Misys Healthcare的合并，以及本公司Physician’s Interactive and Medication Solutions Group的出售。他还在A4 Health Systems、ChannelHealth Incorporated、Advanced Imaging Concepts、RxCentric的收购业务中，发挥了重要的作用。加入Allscripts之前，他是Douglas Elliman-Beitler的首席运营官，这是商业写字楼管理与开发公司，管理着该公司的美国业务。之前，他担任SES Properties的总裁，这是密集持股、完全整合的房地产公司，位于加州Carlsbad。同期，他成立了City Financial Bancorp，并担任其副董事长，负责金融机构的收购、融资、监管事务、法律事务、业务审核与重组，以及最终的出售。他还曾在芝加哥的律师事务所Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg从事过商业法律执业。他目前是Medidata Solutions、Perseus Acquisition LLC Physicians Interactive的董事，以及Kellogg Innovation Network Advisory Board of the Kellogg School of Management, Northwestern University的成员。他还是Gastro-Intestinal Research Foundation的官员、董事。2009-2010，他曾被任命为Economic Recovery Commission of the State of Illinois的成员。
Lee A. Shapiro is currently managing partner and co-founder of 7wire Ventures, a private investment firm that seeks and invests in innovative ideas and entrepreneurs mostly in the areas of healthcare and education. Previously, Mr. Shapiro was president of Allscripts Healthcare Solutions, Inc., a provider of innovative technology solutions, from 2002 to December 2012 where he oversaw the company’s strategy, international operations, health plan initiatives and entrepreneurial business investments, and was a consultant to Allscripts from December 2012 to June 2013. Prior to joining Allscripts, he was the chief operating officer of Douglas Elliman-Beitler, a commercial office management and development company, where he directed all business activities throughout the United States. Mr. Shapiro’s career also includes serving as president of SES Properties, Inc., vice chairman of City Financial Bancorp and practicing commercial law at Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg. Mr. Shapiro was also appointed to the Economic Recovery Commission of the State of Illinois during its seating in 2009-2010. He currently serves on the board of directors of Tivity Health, Inc. f/k/a Healthways, Inc., the largest independent global provider of well-being improvement solutions (where he is chair of the audit committee), and Aptus Health (f/k/a Physicians Interactive Holdings), a subsidiary of Merck. Mr. Shapiro holds a J.D. degree from The University of Chicago Law School and a B.S. in Accounting from the University of Illinois Urbana-Champaign. - Lee A. Shapiro，2002年成为Allscripts的总裁；2000年加入Allscripts。他指导着本公司的战略举措，其中包括最近完成的与Eclipsys and Misys的交易、之前与 Misys Healthcare的合并，以及本公司Physician’s Interactive and Medication Solutions Group的出售。他还在A4 Health Systems、ChannelHealth Incorporated、Advanced Imaging Concepts、RxCentric的收购业务中，发挥了重要的作用。加入Allscripts之前，他是Douglas Elliman-Beitler的首席运营官，这是商业写字楼管理与开发公司，管理着该公司的美国业务。之前，他担任SES Properties的总裁，这是密集持股、完全整合的房地产公司，位于加州Carlsbad。同期，他成立了City Financial Bancorp，并担任其副董事长，负责金融机构的收购、融资、监管事务、法律事务、业务审核与重组，以及最终的出售。他还曾在芝加哥的律师事务所Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg从事过商业法律执业。他目前是Medidata Solutions、Perseus Acquisition LLC Physicians Interactive的董事，以及Kellogg Innovation Network Advisory Board of the Kellogg School of Management, Northwestern University的成员。他还是Gastro-Intestinal Research Foundation的官员、董事。2009-2010，他曾被任命为Economic Recovery Commission of the State of Illinois的成员。
- Lee A. Shapiro is currently managing partner and co-founder of 7wire Ventures, a private investment firm that seeks and invests in innovative ideas and entrepreneurs mostly in the areas of healthcare and education. Previously, Mr. Shapiro was president of Allscripts Healthcare Solutions, Inc., a provider of innovative technology solutions, from 2002 to December 2012 where he oversaw the company’s strategy, international operations, health plan initiatives and entrepreneurial business investments, and was a consultant to Allscripts from December 2012 to June 2013. Prior to joining Allscripts, he was the chief operating officer of Douglas Elliman-Beitler, a commercial office management and development company, where he directed all business activities throughout the United States. Mr. Shapiro’s career also includes serving as president of SES Properties, Inc., vice chairman of City Financial Bancorp and practicing commercial law at Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg. Mr. Shapiro was also appointed to the Economic Recovery Commission of the State of Illinois during its seating in 2009-2010. He currently serves on the board of directors of Tivity Health, Inc. f/k/a Healthways, Inc., the largest independent global provider of well-being improvement solutions (where he is chair of the audit committee), and Aptus Health (f/k/a Physicians Interactive Holdings), a subsidiary of Merck. Mr. Shapiro holds a J.D. degree from The University of Chicago Law School and a B.S. in Accounting from the University of Illinois Urbana-Champaign.
- Thomas L. Tran
-
Thomas L. Tran，2008年7月起，担任本公司的高级副总裁、首席财务官。加入WellCare之前，2007年6月至2008年6月，他担任健康管理公司CareGuide的总裁、首席运营官、首席财务官。2005年7月至2007年6月，他担任的高级副总裁、首席财务官，这是UnitedHealth Group的主要运营业务部之一，UnitedHealth Group从事员工健康医疗福利项目的管理。他在Seton Hall University获得会计学位，在New York University获得财务方向的工商管理硕士学位。
Thomas L. Tran has served as Molina Healthcare, Inc. chief financial officer since June 2018. Mr. Tran has over 35 years of experience in health care. From 2014 to 2018 Mr. Tran was the chief financial officer for Sentry Data Systems. Prior to that, Mr. Tran served as the chief financial officer of WellCare Health Plans, Inc., where he financially managed the company from 2008 to 2014. Mr. Tran also held leadership roles at CareGuide, Uniprise a principal operating division of UnitedHealth Group, ConnectiCare, Blue Cross & Blue Shield of Massachusetts, and Cigna. Mr. Tran earned his Bachelor’s degree from Seton Hall University and his Master of Business Administration degree from New York University. None of the entities where Mr. Tran was previously employed is a parent, subsidiary, or other affiliate of the Company. - Thomas L. Tran，2008年7月起，担任本公司的高级副总裁、首席财务官。加入WellCare之前，2007年6月至2008年6月，他担任健康管理公司CareGuide的总裁、首席运营官、首席财务官。2005年7月至2007年6月，他担任的高级副总裁、首席财务官，这是UnitedHealth Group的主要运营业务部之一，UnitedHealth Group从事员工健康医疗福利项目的管理。他在Seton Hall University获得会计学位，在New York University获得财务方向的工商管理硕士学位。
- Thomas L. Tran has served as Molina Healthcare, Inc. chief financial officer since June 2018. Mr. Tran has over 35 years of experience in health care. From 2014 to 2018 Mr. Tran was the chief financial officer for Sentry Data Systems. Prior to that, Mr. Tran served as the chief financial officer of WellCare Health Plans, Inc., where he financially managed the company from 2008 to 2014. Mr. Tran also held leadership roles at CareGuide, Uniprise a principal operating division of UnitedHealth Group, ConnectiCare, Blue Cross & Blue Shield of Massachusetts, and Cigna. Mr. Tran earned his Bachelor’s degree from Seton Hall University and his Master of Business Administration degree from New York University. None of the entities where Mr. Tran was previously employed is a parent, subsidiary, or other affiliate of the Company.
高管简历
中英对照 | 中文 | 英文- Andrew Toy
Andrew Toy，自2023年1月1日起担任首席执行官，自2018年11月起担任董事会成员。在成为首席执行官之前，他自2019年3月起担任总裁。此前，他还曾在2018年2月至2022年2月期间担任首席技术官。在加入Clover Health之前，从2014年5月到2018年2月，Toy先生就职于跨国科技公司Google LLC。他曾在谷歌云团队工作，负责开发人员平台和智能功能，并领导了安卓的企业平台Android for Work。Toy先生是在2014年5月收购Divide后加入谷歌的，Divide是一家专注于在移动设备上创造工作和个人数据分割的公司。从2010年1月通过收购开始，Toy先生担任Divide的首席执行官、董事和联合创始人。Toy先生拥有斯坦福大学计算机科学学士和硕士学位，他还曾在2000年6月至2001年4月期间担任副讲师。
Andrew Toy,has served as Chief Executive Officer since January 1, 2023, and as a member of Board of Directors since November 2018. Prior to becoming Chief Executive Officer, he had served as President since March 2019. He previously also served as Chief Technology Officer from February 2018 to February 2022. Prior to joining Clover Health, from May 2014 to February 2018, Mr. Toy was at Google LLC, a multinational technology company. He worked on the Google Cloud team where he was responsible for Developer Platform and Intelligence features, and led Android for Work, the enterprise platform for Android. Mr. Toy joined Google as a result of the May 2014 acquisition of Divide, a company focused on creating a split between work and personal data on mobile devices From January 2010 through its acquisition, Mr. Toy was the Chief Executive Officer, a director and co-founder of Divide. Mr. Toy holds a B.S. and an M.S. in computer science from Stanford University, where he has also served as an associate lecturer from June 2000 to April 2001.- Andrew Toy，自2023年1月1日起担任首席执行官，自2018年11月起担任董事会成员。在成为首席执行官之前，他自2019年3月起担任总裁。此前，他还曾在2018年2月至2022年2月期间担任首席技术官。在加入Clover Health之前，从2014年5月到2018年2月，Toy先生就职于跨国科技公司Google LLC。他曾在谷歌云团队工作，负责开发人员平台和智能功能，并领导了安卓的企业平台Android for Work。Toy先生是在2014年5月收购Divide后加入谷歌的，Divide是一家专注于在移动设备上创造工作和个人数据分割的公司。从2010年1月通过收购开始，Toy先生担任Divide的首席执行官、董事和联合创始人。Toy先生拥有斯坦福大学计算机科学学士和硕士学位，他还曾在2000年6月至2001年4月期间担任副讲师。
- Andrew Toy,has served as Chief Executive Officer since January 1, 2023, and as a member of Board of Directors since November 2018. Prior to becoming Chief Executive Officer, he had served as President since March 2019. He previously also served as Chief Technology Officer from February 2018 to February 2022. Prior to joining Clover Health, from May 2014 to February 2018, Mr. Toy was at Google LLC, a multinational technology company. He worked on the Google Cloud team where he was responsible for Developer Platform and Intelligence features, and led Android for Work, the enterprise platform for Android. Mr. Toy joined Google as a result of the May 2014 acquisition of Divide, a company focused on creating a split between work and personal data on mobile devices From January 2010 through its acquisition, Mr. Toy was the Chief Executive Officer, a director and co-founder of Divide. Mr. Toy holds a B.S. and an M.S. in computer science from Stanford University, where he has also served as an associate lecturer from June 2000 to April 2001.
- Peter Kuipers
Peter Kuipers，自2024年5月起担任首席财务官。在加入Clover之前，2015年8月至2023年8月，Kuipers先生在Omnicell, Inc.技术公司TERM1担任执行副总裁兼首席财务官，在那里他提供财务领导和战略眼光。在全细胞医护科技，他还直接领导了其他各种关键职能，包括全球供应链&制造、信息技术、国际业务、企业发展和并购。在加入全细胞医护科技之前，Kuipers先生曾在QuantCast和The Weather Company担任首席财务官，在Yahoo！、艾尔特拉公司（已被英特尔收购）、通用电气公司和阿克苏诺贝尔担任部门首席财务官和执行FP & A领导职务。Kuipers先生的职业生涯始于安永，在那里他专注于财务审计、IPO服务以及跨国公司的并购尽职调查。获马斯特里赫特大学商业与经济学院经济学和工商管理硕士学位，荷兰特许会计师。
Peter Kuipers,has served as Chief Financial Officer since May 2024. Prior to joining Clover, from August 2015 to August 2023, Mr. Kuipers served as Executive Vice President and Chief Financial Officer at Omnicell, Inc., a healthcare technology company, where he provided financial leadership and strategic vision. At Omnicell, he also directly led various other critical functions, including global supply chain & manufacturing, information technology, international business, corporate development, and M&A. Before Omnicell, Mr. Kuipers served as the Chief Financial Officer at Quantcast and The Weather Company, as well as divisional Chief Financial Officer and executive FP&A leadership roles at Yahoo!, Altera Corporation (acquired by Intel), General Electric Company, and Akzo Nobel. Mr. Kuipers started his career at Ernst & Young where he focused on financial audits, IPO services, and M&A due diligence for multinational companies. He received a Master's Degree in Economics and Business Administration from the Maastricht University School of Business and Economics, and is a Chartered Accountant in the Netherlands.- Peter Kuipers，自2024年5月起担任首席财务官。在加入Clover之前，2015年8月至2023年8月，Kuipers先生在Omnicell, Inc.技术公司TERM1担任执行副总裁兼首席财务官，在那里他提供财务领导和战略眼光。在全细胞医护科技，他还直接领导了其他各种关键职能，包括全球供应链&制造、信息技术、国际业务、企业发展和并购。在加入全细胞医护科技之前，Kuipers先生曾在QuantCast和The Weather Company担任首席财务官，在Yahoo！、艾尔特拉公司（已被英特尔收购）、通用电气公司和阿克苏诺贝尔担任部门首席财务官和执行FP & A领导职务。Kuipers先生的职业生涯始于安永，在那里他专注于财务审计、IPO服务以及跨国公司的并购尽职调查。获马斯特里赫特大学商业与经济学院经济学和工商管理硕士学位，荷兰特许会计师。
- Peter Kuipers,has served as Chief Financial Officer since May 2024. Prior to joining Clover, from August 2015 to August 2023, Mr. Kuipers served as Executive Vice President and Chief Financial Officer at Omnicell, Inc., a healthcare technology company, where he provided financial leadership and strategic vision. At Omnicell, he also directly led various other critical functions, including global supply chain & manufacturing, information technology, international business, corporate development, and M&A. Before Omnicell, Mr. Kuipers served as the Chief Financial Officer at Quantcast and The Weather Company, as well as divisional Chief Financial Officer and executive FP&A leadership roles at Yahoo!, Altera Corporation (acquired by Intel), General Electric Company, and Akzo Nobel. Mr. Kuipers started his career at Ernst & Young where he focused on financial audits, IPO services, and M&A due diligence for multinational companies. He received a Master's Degree in Economics and Business Administration from the Maastricht University School of Business and Economics, and is a Chartered Accountant in the Netherlands.
- Karen Soares
Karen Soares是总法律顾问，她自2023年10月以来一直担任该职位。2018年9月至2023年10月，她曾在Clover Health法律部门担任其他各种职务，最近担任Clover Health高级副总裁、副总法律顾问。在加入Clover Health之前，2012年10月至2018年8月，Soares女士曾担任远程医疗初创公司Analyte Health的总法律顾问和首席合规官。2005年10月至2012年9月，她在国际律师事务所Fried，Frank，Harris，Shriver & Jacobson LLP担任合伙人。Soares女士拥有达特茅斯学院的学士学位和芝加哥大学法学院的法学博士学位。
Karen Soares,is General Counsel, a position she has held since October 2023. From September 2018 to October 2023 she served in various other roles within Clover Health's legal department, and most recently served as Clover Health's Senior Vice President, Deputy General Counsel. Before joining Clover Health, from October 2012 to August 2018, Ms. Soares served as the General Counsel and Chief Compliance Officer of Analyte Health, a telehealth startup. From October 2005 to September 2012, she served as an associate at Fried, Frank, Harris, Shriver & Jacobson LLP, an international law firm. Ms. Soares holds a B.A. from Dartmouth College and a J.D. from the University of Chicago Law School.- Karen Soares是总法律顾问，她自2023年10月以来一直担任该职位。2018年9月至2023年10月，她曾在Clover Health法律部门担任其他各种职务，最近担任Clover Health高级副总裁、副总法律顾问。在加入Clover Health之前，2012年10月至2018年8月，Soares女士曾担任远程医疗初创公司Analyte Health的总法律顾问和首席合规官。2005年10月至2012年9月，她在国际律师事务所Fried，Frank，Harris，Shriver & Jacobson LLP担任合伙人。Soares女士拥有达特茅斯学院的学士学位和芝加哥大学法学院的法学博士学位。
- Karen Soares,is General Counsel, a position she has held since October 2023. From September 2018 to October 2023 she served in various other roles within Clover Health's legal department, and most recently served as Clover Health's Senior Vice President, Deputy General Counsel. Before joining Clover Health, from October 2012 to August 2018, Ms. Soares served as the General Counsel and Chief Compliance Officer of Analyte Health, a telehealth startup. From October 2005 to September 2012, she served as an associate at Fried, Frank, Harris, Shriver & Jacobson LLP, an international law firm. Ms. Soares holds a B.A. from Dartmouth College and a J.D. from the University of Chicago Law School.
- Brady Priest
布雷迪·普里斯特（Brady Priest）是家庭护理部门的首席执行官，他自2022年7月以来一直担任该职位。此前，从2020年7月至2022年7月，Priest先生担任SeekMedicare的首席执行官，SeekMedicare是一家现场营销组织，是Priest先生共同创立的公司的前间接全资子公司。Priest先生此前曾在Clover Health担任多个职务，包括2018年9月至2021年9月的顾问以及2016年6月至2018年9月的总法律顾问。从2018年10月至2020年6月，Priest先生担任联合健康研发部门的总法律顾问，在2016年6月之前，他曾在联合健康担任多个职务。普里斯特先生拥有米德尔伯里学院的学士学位和布鲁克林法学院的法学博士学位。
Brady Priest,is Chief Executive Officer of Home Care, a position he has held since July 2022. Previously, from July 2020 to July 2022, Mr. Priest served as Chief Executive Officer of SeekMedicare, a field marketing organization and a former indirect wholly-owned subsidiary of the Company that Mr. Priest co-founded. Mr. Priest previously held several roles with Clover Health, including Advisor from September 2018 to September 2021 and General Counsel from June 2016 to September 2018. From October 2018 to June 2020, Mr. Priest served as the General Counsel of UnitedHealth Group's Research & Development arm, and prior to June 2016, he held various roles within UnitedHealth Group. Mr. Priest holds a B.A. from Middlebury College, and a J.D. from Brooklyn Law School.- 布雷迪·普里斯特（Brady Priest）是家庭护理部门的首席执行官，他自2022年7月以来一直担任该职位。此前，从2020年7月至2022年7月，Priest先生担任SeekMedicare的首席执行官，SeekMedicare是一家现场营销组织，是Priest先生共同创立的公司的前间接全资子公司。Priest先生此前曾在Clover Health担任多个职务，包括2018年9月至2021年9月的顾问以及2016年6月至2018年9月的总法律顾问。从2018年10月至2020年6月，Priest先生担任联合健康研发部门的总法律顾问，在2016年6月之前，他曾在联合健康担任多个职务。普里斯特先生拥有米德尔伯里学院的学士学位和布鲁克林法学院的法学博士学位。
- Brady Priest,is Chief Executive Officer of Home Care, a position he has held since July 2022. Previously, from July 2020 to July 2022, Mr. Priest served as Chief Executive Officer of SeekMedicare, a field marketing organization and a former indirect wholly-owned subsidiary of the Company that Mr. Priest co-founded. Mr. Priest previously held several roles with Clover Health, including Advisor from September 2018 to September 2021 and General Counsel from June 2016 to September 2018. From October 2018 to June 2020, Mr. Priest served as the General Counsel of UnitedHealth Group's Research & Development arm, and prior to June 2016, he held various roles within UnitedHealth Group. Mr. Priest holds a B.A. from Middlebury College, and a J.D. from Brooklyn Law School.
- Jamie L. Reynoso
Jamie L. Reynoso是Medicare Advantage的首席执行官，她自2023年1月以来一直担任该职位。此前，她曾于2020年7月至2023年1月担任首席运营官。在加入Clover Health之前，2016年4月至2019年12月，雷诺索女士担任Memorial Hermann Health Plan的首席运营官，随后担任该计划的首席执行官，该计划是一家由供应商赞助的健康计划。2012年11月至2016年4月，她在大型国家医院系统Catholic Health Initiatives担任Payer战略和运营区域副总裁。在此之前，她曾在联合健康工作超16年，担任过多个职务，包括新兴业务副总裁。雷诺索女士拥有得克萨斯农工大学-金斯维尔分校的学士学位。
Jamie L. Reynoso,is Chief Executive Officer of Medicare Advantage, a position she has held since January 2023. Previously she served as Chief Operating Officer from July 2020 to January 2023. Before joining Clover Health, from April 2016 to December 2019, Ms. Reynoso served as Chief Operating Officer and then Chief Executive Officer of Memorial Hermann Health Plan, a provider-sponsored health plan. From November 2012 to April 2016, she served as Regional Vice President of Payer Strategy and Operations with Catholic Health Initiatives, a large national hospital system. Prior to that, she spent over 16 years at UnitedHealth Group, where she held various roles including Vice President of Emerging Business. Ms. Reynoso holds a B.B.A. from Texas A&M University-Kingsville.- Jamie L. Reynoso是Medicare Advantage的首席执行官，她自2023年1月以来一直担任该职位。此前，她曾于2020年7月至2023年1月担任首席运营官。在加入Clover Health之前，2016年4月至2019年12月，雷诺索女士担任Memorial Hermann Health Plan的首席运营官，随后担任该计划的首席执行官，该计划是一家由供应商赞助的健康计划。2012年11月至2016年4月，她在大型国家医院系统Catholic Health Initiatives担任Payer战略和运营区域副总裁。在此之前，她曾在联合健康工作超16年，担任过多个职务，包括新兴业务副总裁。雷诺索女士拥有得克萨斯农工大学-金斯维尔分校的学士学位。
- Jamie L. Reynoso,is Chief Executive Officer of Medicare Advantage, a position she has held since January 2023. Previously she served as Chief Operating Officer from July 2020 to January 2023. Before joining Clover Health, from April 2016 to December 2019, Ms. Reynoso served as Chief Operating Officer and then Chief Executive Officer of Memorial Hermann Health Plan, a provider-sponsored health plan. From November 2012 to April 2016, she served as Regional Vice President of Payer Strategy and Operations with Catholic Health Initiatives, a large national hospital system. Prior to that, she spent over 16 years at UnitedHealth Group, where she held various roles including Vice President of Emerging Business. Ms. Reynoso holds a B.B.A. from Texas A&M University-Kingsville.
- Conrad Wai
Conrad Wai，是Counterpart Health，Inc.的首席执行官，该全资子公司专注于软件即服务和技术支持服务解决方案，将Clover Assistant技术的力量带给服务于Medicare合格人群的外部支付者和提供者。Wai先生自2024年9月以来一直担任这一职务。在成为Counterpart Health，Inc.首席执行官之前，Mr. Wai自2022年2月起担任首席技术官。在加入Clover之前，Wai先生于2021年2月至2021年9月担任数字健康初创公司Hinge Health的产品高级副总裁，并于2019年3月至2021年1月担任产品和设计副总裁。他于2014年至2017年在雅虎担任产品管理职务，随后于2017年至2018年在威瑞森通信媒体担任产品管理运营副总裁，此前雅虎在其任职期间被威瑞森通信媒体收购。Wai先生同时拥有斯坦福大学计算机科学学士和硕士学位。
Conrad Wai,is the Chief Executive Officer of Counterpart Health, Inc., wholly-owned subsidiary focused on software-as-a-service and tech enabled services solution to has the power of Clover Assistant technology to external payors and providers serving the Medicare eligible population. Mr. Wai has held this position since September 2024. Prior to becoming CEO of Counterpart Health, Inc., Mr. Wai served as Chief Technology Officer since February 2022. Prior to joining Clover, Mr. Wai was the Senior Vice President of Product at Hinge Health, a digital health startup, from February 2021 to September 2021 and the Vice President of Product and Design from March 2019 to January 2021. He served in product management roles at Yahoo from 2014 to 2017 and then as Operating Vice President of Product Management at Verizon Media from 2017 to 2018 after Yahoo was acquired by Verizon Media during his tenure. Mr. Wai holds both a B.S. and M.S. in computer science from Stanford University.- Conrad Wai，是Counterpart Health，Inc.的首席执行官，该全资子公司专注于软件即服务和技术支持服务解决方案，将Clover Assistant技术的力量带给服务于Medicare合格人群的外部支付者和提供者。Wai先生自2024年9月以来一直担任这一职务。在成为Counterpart Health，Inc.首席执行官之前，Mr. Wai自2022年2月起担任首席技术官。在加入Clover之前，Wai先生于2021年2月至2021年9月担任数字健康初创公司Hinge Health的产品高级副总裁，并于2019年3月至2021年1月担任产品和设计副总裁。他于2014年至2017年在雅虎担任产品管理职务，随后于2017年至2018年在威瑞森通信媒体担任产品管理运营副总裁，此前雅虎在其任职期间被威瑞森通信媒体收购。Wai先生同时拥有斯坦福大学计算机科学学士和硕士学位。
- Conrad Wai,is the Chief Executive Officer of Counterpart Health, Inc., wholly-owned subsidiary focused on software-as-a-service and tech enabled services solution to has the power of Clover Assistant technology to external payors and providers serving the Medicare eligible population. Mr. Wai has held this position since September 2024. Prior to becoming CEO of Counterpart Health, Inc., Mr. Wai served as Chief Technology Officer since February 2022. Prior to joining Clover, Mr. Wai was the Senior Vice President of Product at Hinge Health, a digital health startup, from February 2021 to September 2021 and the Vice President of Product and Design from March 2019 to January 2021. He served in product management roles at Yahoo from 2014 to 2017 and then as Operating Vice President of Product Management at Verizon Media from 2017 to 2018 after Yahoo was acquired by Verizon Media during his tenure. Mr. Wai holds both a B.S. and M.S. in computer science from Stanford University.